Domov › Nazivi delovnih mest › Validation Engineer II
Validation Engineer II: plače H-1B
105 vlog za delovne pogoje je uporabilo naziv Validation Engineer II. Medianna osnovna plača $97.000; srednja polovica $89.604–$103.250.
Vloge (LCA)105
Mediana ponujene plače$97.000
Sredina razpona plač$89.604–$103.250
10.–90. percentil$85.000–$120.000
Ste advokat za priseljevanje, kadrovik ali delodajalec? Predstavite svojo storitev na vrhu te strani — $99 za 30 dni →
Delodajalci
| Delodajalec | LCA | Mediana plače |
|---|
| Azzur Group DBA, Azzur Consulting LLC | 11 | $99.999 |
| Azzur Group LLC dba Azzur Consulting LLC | 10 | $96.999 |
| Total Validation Services, Inc. | 4 | $125.000 |
| PSC Biotech Corporation | 4 | $85.296 |
| Azzur Consulting LLC | 4 | $90.000 |
| Emd Millipore Corporation | 4 | $100.000 |
| Alcami Carolinas Corporation | 4 | $103.811 |
| Rani Therapeutics, LLC | 3 | $120.000 |
| Nitto Denko Avecia, Inc. | 3 | $85.000 |
| Intellectt, Inc. | 3 | $97.760 |
| Alkermes, Inc. | 3 | $90.000 |
| Akorn Operating Company LLC | 2 | $89.604 |
| Azzur Group LLC | 2 | $100.000 |
| Just-Evotec Biologics, Inc. | 2 | $100.000 |
| Amneal Pharmaceuticals, LLC | 2 | $84.343 |
| Fagron Compounding Services LLC | 2 | $79.238 |
| Mangan Inc. | 2 | $101.840 |
| Visual Technologies LLC | 2 | $90.646 |
| Woodstock Sterile Solutions, Inc. | 2 | $85.540 |
| Hyde Engineering and Consulting, Inc. | 2 | $85.000 |
| Kite Pharma Inc. | 2 | $93.880 |
| P & L Development LLC | 2 | $107.952 |
| Civica, Inc. | 2 | $142.500 |
| Cook Polymer Technology | 2 | $86.750 |
| IT Minds, LLC | 2 | $95.358 |
| FUJIFILM Diosynth Biotechnologies Texas LLC | 1 | $85.000 |
| Masy Systems, Inc. | 1 | $101.899 |
| Alps Alpine North America, Inc. | 1 | $79.186 |
| Motional AD Inc. | 1 | $93.350 |
| Matica Biotechnology, Inc. | 1 | $60.091 |
| Meso Scale Diagnostics, LLC | 1 | $116.050 |
| Charles River Laboratories, Inc. | 1 | $110.000 |
| Veqtor LLC | 1 | $96.400 |
| Shire Human Genetic Therapies Inc. | 1 | $98.000 |
| Techno Pro Solutions, Inc. | 1 | $89.440 |
| VAStek Inc. | 1 | — |
| Amneal Pharmaceuticals of New York | 1 | $99.000 |
| Rivian Automotive, LLC | 1 | $111.384 |
| Fresenius USA Manufacturing, Inc., a Fresenius Medical Care N.A. company | 1 | $88.000 |
| Replimune Inc. | 1 | $148.000 |
| KBI Biopharma, Inc. | 1 | $93.038 |
| Silicon Laboratories, Inc. | 1 | $140.000 |
| Quality Agents, LLC | 1 | $99.000 |
| Empower Clinic Services, L.L.C. | 1 | $112.000 |
| HL Mando America Corporation | 1 | $93.642 |
| Exelead Inc. | 1 | $86.000 |
| Eliquent Life Sciences | 1 | $86.902 |
| Medtronic, Inc. | 1 | $102.669 |
| Sigma-Aldrich Manufacturing LLC | 1 | $95.000 |
Po plačilnem razredu
| Raven plače | Mediana plače |
|---|
| Stopnja I (začetna) | $90.000 |
| Stopnja II (kvalificirana) | $97.418 |
| Stopnja III (izkušena) | $114.340 |
| Stopnja IV (polno usposobljena) | $100.046 |
Department of Labor določi štiri stopnje prevladujočih plač za vsak poklic in območje, od Stopnje I (začetna) do Stopnje IV (popolna usposobljenost). Delodajalec izbere stopnjo, ki ustreza zahtevam delovnega mesta.
Po fiskalnem letu
| Poslovno leto | LCA | Mediana plače |
|---|
| Fy2023 | 38 | $95.700 |
| Fy2024 | 15 | $89.996 |
| Fy2025 | 33 | $99.999 |
| Fy2026 | 18 | $97.589 |
Mesta
- Waltham, MA6
- Hatboro, PA5
- West Point, PA4
- San Jose, CA3
- Cincinnati, OH3
- Morrisville, NC3
- Albuquerque, NM3
- Amityville, NY2
- Laurel, MD2
- College Station, TX2
- Redmond, WA2
- Berkeley, CA2
- Brisbane, CA2
- Rockville, MD2
- Piscataway, NJ2
- Wichita, KS2
- South San Francisco, CA2
- Bedford, MA2
- East Hanover, NJ2
- Davie, FL2
- Woodstock, IL2
- El Segundo, CA2
- Fredericksburg, VA2
- Wilmington, OH2
- Copiague, NY2
- Jaffrey, NH2
- Petersburg, VA2
- Raleigh, NC2
- Lebanon, IN2
- St. Louis, MO2
Plače so spodnja meja ponujene plače pri vsaki vlogi, pretvorjene v letni znesek; statistika uporablja samo potrjene vloge za polni delovni čas. LCA ni odobritev vizuma, ena LCA pa lahko pokriva več delovnih mest. Vir: U.S. Department of Labor, OFLC LCA Disclosure Data, davčna leta 2023–2026 (najnovejša odločitev 30. jun. 2026).